Method for predicting a drug transport capability by abcg2 polymorphisms
CA 2489474 A1 · Owner: Kotani, Hidehito · Inventors: Kotani, Hidehito; Mizuarai, Shinji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides polymorphisms of ABCG2 polypeptide and polynucleotide coding therefor, which is related to the intracellular accumulation of indolocarbazole compounds as well as methods for detecting , the polymorphisms comprising collecting a sample from mammals and , determining a polymorphism of the nucleotide sequence of ABCG2 gene or a polymorphism of the amino acid sequence of ABCG2 polypeptide.In a preferred embodiment of the present invention, the polymorphism of the nucleotide sequence is one or more of single nucleotide polymorphisms at positions selected from the group consisting of 34 376 and 421 of SEQ ID NO:1, and the , polymorphism of the amino acid …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 13, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 13, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 13, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.